Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Neil Hayes

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
Cancer Research|December 11, 2013
Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitinationBridgid E Hast, Erica W Cloer, Dennis Goldfarb, et al.
BMC Bioinformatics|September 6, 2012
ReQON: a Bioconductor package for recalibrating quality scores from next-generation sequencing dataChristopher R Cabanski, Keary Cavin, Chris Bizon, et al.
American Journal of Otolaryngology|November 5, 2020
Decreased overall survival in black patients with HPV-associated oropharyngeal cancerSiddharth Sheth, Douglas R Farquhar, Nicholas R Lenze, et al.
Plos One|October 3, 2013
The LKB1 tumor suppressor as a biomarker in mouse and human tissuesYuji Nakada, Thomas G Stewart, Christopher G Peña, et al.
Cancers|June 28, 2023
Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic SubtypesRonald C Eldridge, Zhaohui S Qin, Nabil F Saba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancerCarrie B Lee, Thomas E Stinchcombe, Dominic T Moore, et al.
Nature Communications|January 13, 2021
SCISSOR: a framework for identifying structural changes in RNA transcriptsHyo Young Choi, Heejoon Jo, Xiaobei Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2008
Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancerThomas E Stinchcombe, David E Morris, Carrie B Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell CarcinomasAnders Berglund, Clarisse Muenyi, Erin M Siegel, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Lung Adenocarcinoma Just Desserts: An Expanding Pie of Activating Oncogenes or a Layer Cake of Integrated AlterationsMinjeong Kim, Wisut Lamlertthon, Heejoon Jo, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Cancer Research|December 11, 2013
Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitinationBridgid E Hast, Erica W Cloer, Dennis Goldfarb, et al.
BMC Bioinformatics|September 6, 2012
ReQON: a Bioconductor package for recalibrating quality scores from next-generation sequencing dataChristopher R Cabanski, Keary Cavin, Chris Bizon, et al.
American Journal of Otolaryngology|November 5, 2020
Decreased overall survival in black patients with HPV-associated oropharyngeal cancerSiddharth Sheth, Douglas R Farquhar, Nicholas R Lenze, et al.
Plos One|October 3, 2013
The LKB1 tumor suppressor as a biomarker in mouse and human tissuesYuji Nakada, Thomas G Stewart, Christopher G Peña, et al.
Cancers|June 28, 2023
Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic SubtypesRonald C Eldridge, Zhaohui S Qin, Nabil F Saba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancerCarrie B Lee, Thomas E Stinchcombe, Dominic T Moore, et al.
Nature Communications|January 13, 2021
SCISSOR: a framework for identifying structural changes in RNA transcriptsHyo Young Choi, Heejoon Jo, Xiaobei Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2008
Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancerThomas E Stinchcombe, David E Morris, Carrie B Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell CarcinomasAnders Berglund, Clarisse Muenyi, Erin M Siegel, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Lung Adenocarcinoma Just Desserts: An Expanding Pie of Activating Oncogenes or a Layer Cake of Integrated AlterationsMinjeong Kim, Wisut Lamlertthon, Heejoon Jo, et al.
Pageof 18